Skip to main content
Premium Trial:

Request an Annual Quote

Isis Pharmaceuticals Purchases Pangea's Integrated Applications

Premium

OAKLAND, Calif.--Pangea Systems announced that it has provided Isis Pharmaceuticals with its integrated software applications and a database aimed at accelerating drug discovery to treat numerous diseases.

Isis will use the GeneWorld software application and GeneThesaurus subscription service to research antisense molecules. Pangea said its software will provide Isis with a cost-effective, customizable database backbone for accelerated research.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.